|
New
Sophisticated
Pacemaker
-
PULSAR
MAX
II
-
Hits
U.S.
Market
System
Combines
Sensor
and
Diagnostic
Capabilities
To
Enhance
Therapy
Delivery
May
3,
2001--Guidant
Corporation,
a
global
leader
in
cardiac
and
vascular
technology,
today
announced
the
U.S.
market
release
of
its
most
sophisticated
pacemaker
ever
-
the
PULSAR
MAX
II
pacing
system.
The
PULSAR
MAX
II
pacemaker
system
incorporates
Guidant's
separate,
simultaneous
dual-chamber
electrograms,
which
are
unique
in
the
industry.
This
diagnostic
tool
provides
a
record
of
both
atrial
and
ventricular
heart
rhythms
to
help
physicians
make
therapy
decisions.
The
PULSAR
MAX
II
system
adds
two
new
features
-
Onset
Electrograms
and
Event
Markers
--
that
help
make
it
easier
for
physicians
to
assess
the
origin
and
type
of
arrhythmic
events.
``These
electrograms
give
physicians
valuable
information
about
the
presence
or
absence
of
arrhythmias
that
guide
us
in
taking
actions
to
make
patients
feel
better,''
said
James
Coman,
M.D.,
FACC,
Oklahoma
Heart
Institute,
Tulsa.
``For
example,
based
on
electrograms,
we
may
be
able
to
reduce
the
amount
of
medications
patients
take
that
make
them
feel
tired
or
sluggish.''
Another
new
feature
of
the
PULSAR
MAX
II
pacemaker
system
is
designed
for
patients
suffering
from
atrial
arrhythmias.
This
new
feature,
Ventricular
Rate
Regulation,
provides
pacing
at
regular
intervals
in
the
ventricle
during
atrial
arrhythmias.
The
PULSAR
MAX
II
system
also
incorporates
the
highly
successful
blended
sensor
found
in
the
PULSAR
MAX
pacemaker.
It
combines
input
from
two
sensors
--
a
minute-ventilation
sensor
that
measures
respiratory
rate
and
tidal
volume,
and
an
accelerometer
that
measures
motion.
By
blending
the
two
inputs,
the
pacemaker
can
appropriately
increase
heart
rate
based
on
workload,
not
just
forward
motion.
For
example,
the
PULSAR
MAX
II
pacing
system
provides
a
different
heart
rate
for
a
person
going
for
a
walk
than
for
the
same
person
going
for
a
walk
carrying
a
small
child.
``The
sensor
in
the
PULSAR
MAX
pacemaker
family
more
closely
approximates
the
heart's
natural
pacemaker
-
the
sinus
node
-
than
any
pacemaker
on
the
market
today,''
Dr.
Coman
said.
``My
PULSAR
MAX
patients
are
the
happiest
patients
in
my
practice.
I
now
often
run
late
in
my
pacemaker
clinic
because
my
PULSAR
MAX
patients
want
to
tell
me
all
about
how
great
they
feel.''
``Pacemakers
are
no
longer
just
for
sustaining
life,
they
are
also
for
enhancing
life,''
said
Guidant's
Fred
McCoy,
president,
cardiac
rhythm
management.
``Our
good
news
for
patients
and
their
physicians
is
that
certain
symptoms
people
may
associate
with
normal
aging,
such
as
shortness
of
breath
or
fatigue,
may
well
be
addressed
with
our
advanced
technologies
such
as
the
PULSAR
MAX
II
system,''
he
said.
A
global
leader
in
the
medical
technology
industry,
Guidant
Corporation
provides
innovative,
minimally
invasive
and
cost-effective
products
and
services
for
the
treatment
of
cardiovascular
and
vascular
disease.
For
more
information
on
Guidant's
products
and
services,
visit
the
company's
web
site
at
www.guidant.com.
|